S. Thum-Oltmer

SCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups

L. Klimek, G. Fox, S. Thum-Oltmer, 2018, Allergo Journal International.

Hypoallergenic high-dose immunotherapy proves effective and safe in a multicentre surveillance study

G. Hoheisel, S. Thum-Oltmer, E. Martín, 2012, Allergo Journal.

Vaccination during concurrent subcutaneous immunotherapy: safety of simultaneous application.

S. Thum-Oltmer, D. Ullrich, K. Ullrich, 2015, European annals of allergy and clinical immunology.

Hypoallergenic preparations in SCIT

R. Brehler, H. Kahlert, S. Thum-Oltmer, 2010 .

Patients’ compliance with different administration routes for allergen immunotherapy in Germany

S. Thum-Oltmer, S. Mussler, Anne-Marie Egert-Schmidt, 2014, Patient preference and adherence.

Patients’ compliance with different administration routes for allergen immunotherapy in germany

S. Thum-Oltmer, S. Mussler, J. Kolbe, 2014 .